How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

7,238 results for

Diarrhea Secondary to Medications

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

161. Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation

(suction curettage or D&C) for any reason Secondary Outcome Measures : Proportion of Individual Side Effects Experienced by Participants [ Time Frame: 7-14 days ] Side effects include diarrhea, nausea, vomiting, fever, chills, headaches, dizziness and/or weakness experienced by participants Proportion of Women Who Determine Method Acceptable [ Time Frame: 7-14 days ] overall acceptability, time to complete abortion, bleeding, side effects, pain Proportion of Providers Who Determine Method Acceptable (...) Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more

2014 Clinical Trials

162. The Effectiveness and Cost-effectiveness of Medical Advice Given by Telephone for Patients Calling for Primary Care

by a general practitioner or in an emergency department, during out-of-hours periods Secondary Outcome Measures : Cost effectiveness [ Time Frame: at 15 days ] Cost effectiveness based on the economic analysis in each arm (sick leaves, hospitalization, EMS or firemen use...) Care Mobile Units use [ Time Frame: at 15 days ] Emergency Medical Service use [ Time Frame: at 15 days ] Firemen use [ Time Frame: at 15 days ] Number of fireman use Recall at dispatching centre [ Time Frame: at 15 days ] Number (...) The Effectiveness and Cost-effectiveness of Medical Advice Given by Telephone for Patients Calling for Primary Care The Effectiveness and Cost-effectiveness of Medical Advice Given by Telephone for Patients Calling for Primary Care - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number

2014 Clinical Trials

163. Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis

Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Ussing Experiments to Evaluate the Role of Medication-induced Microscopic Colitis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02303132 Recruitment Status : Completed First Posted : November 27, 2014 Last Update Posted : July 19, 2016 Sponsor: Maastricht University Medical Center

2014 Clinical Trials

164. Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2

disease physicians, gastroenterologists, psychiatrists, nutritionists, pharmacists, social workers, financial coordinators, etc.; managing medication regimens to prevent infections, GVHD, and other complications (not to mention avoiding drug and food interactions); adjusting to multiple side effects including fatigue, weakness, anorexia, nausea, vomiting, diarrhea, rashes, pain, anxiety, stress, organ failure, etc.; the sheer amount of time required for healthcare visits, lab draws, waiting (...) Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2 Medical Home Care for Hematopoietic Stem Cell Transplantation Phase 2 - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Medical Home Care

2014 Clinical Trials

165. Medical Treatment of Stroke (Diagnosis)

stroke prevention may include the use of antihypertensive medications, anticoagulants, platelet antiaggregants, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), smoking cessation, dietary intervention, weight loss, and exercise. Modifiable risk factors include the following: Hypertension Air pollution Cigarette smoking Diabetes Dyslipidemia Atrial fibrillation Sickle cell disease Postmenopausal HRT Depression Diet and activity Weight and body fat Secondary Prevention (...) of Stroke Secondary prevention can be summarized by the mnemonic A, B, C, D, E, as follows: A - Antiaggregants (aspirin, clopidogrel, extended-release dipyridamole, ticlopidine) and anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban, warfarin) B - Blood pressure–lowering medications C - Cessation of cigarette smoking, cholesterol-lowering medications, carotid revascularization D - Diet E – Exercise Smoking cessation, blood pressure control, diabetes control, a low-fat diet (eg, Dietary

2014 eMedicine.com

166. Medical Treatment of Stroke (Overview)

stroke prevention may include the use of antihypertensive medications, anticoagulants, platelet antiaggregants, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), smoking cessation, dietary intervention, weight loss, and exercise. Modifiable risk factors include the following: Hypertension Air pollution Cigarette smoking Diabetes Dyslipidemia Atrial fibrillation Sickle cell disease Postmenopausal HRT Depression Diet and activity Weight and body fat Secondary Prevention (...) of Stroke Secondary prevention can be summarized by the mnemonic A, B, C, D, E, as follows: A - Antiaggregants (aspirin, clopidogrel, extended-release dipyridamole, ticlopidine) and anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban, warfarin) B - Blood pressure–lowering medications C - Cessation of cigarette smoking, cholesterol-lowering medications, carotid revascularization D - Diet E – Exercise Smoking cessation, blood pressure control, diabetes control, a low-fat diet (eg, Dietary

2014 eMedicine.com

167. Medical Treatment of Stroke (Treatment)

stroke prevention may include the use of antihypertensive medications, anticoagulants, platelet antiaggregants, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), smoking cessation, dietary intervention, weight loss, and exercise. Modifiable risk factors include the following: Hypertension Air pollution Cigarette smoking Diabetes Dyslipidemia Atrial fibrillation Sickle cell disease Postmenopausal HRT Depression Diet and activity Weight and body fat Secondary Prevention (...) of Stroke Secondary prevention can be summarized by the mnemonic A, B, C, D, E, as follows: A - Antiaggregants (aspirin, clopidogrel, extended-release dipyridamole, ticlopidine) and anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban, warfarin) B - Blood pressure–lowering medications C - Cessation of cigarette smoking, cholesterol-lowering medications, carotid revascularization D - Diet E – Exercise Smoking cessation, blood pressure control, diabetes control, a low-fat diet (eg, Dietary

2014 eMedicine.com

168. Medical Treatment of Stroke (Follow-up)

stroke prevention may include the use of antihypertensive medications, anticoagulants, platelet antiaggregants, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins), smoking cessation, dietary intervention, weight loss, and exercise. Modifiable risk factors include the following: Hypertension Air pollution Cigarette smoking Diabetes Dyslipidemia Atrial fibrillation Sickle cell disease Postmenopausal HRT Depression Diet and activity Weight and body fat Secondary Prevention (...) of Stroke Secondary prevention can be summarized by the mnemonic A, B, C, D, E, as follows: A - Antiaggregants (aspirin, clopidogrel, extended-release dipyridamole, ticlopidine) and anticoagulants (apixaban, dabigatran, edoxaban, rivaroxaban, warfarin) B - Blood pressure–lowering medications C - Cessation of cigarette smoking, cholesterol-lowering medications, carotid revascularization D - Diet E – Exercise Smoking cessation, blood pressure control, diabetes control, a low-fat diet (eg, Dietary

2014 eMedicine.com

169. Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India

Health Projects Collaborators: Sri B. M. Patil Medical College, Bijapur, Karnataka, India Jawaharlal Nehru Medical College University of Illinois at Chicago University of California, San Francisco Information provided by (Responsible Party): Gynuity Health Projects Study Details Study Description Go to Brief Summary: This study compares two community-level strategies: selective administration of 800 mcg sublingual misoprostol to women at 350 mL blood loss for secondary prevention of postpartum (...) Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2011 Clinical Trials

170. Brilinta (ticagrelor) Tablets - medical review

Brilinta (ticagrelor) Tablets - medical review CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 022433Orig1s000 MEDICAL REVIEW(S) DIVISION OF CARDIOVASCULAR AND RENAL PRODUCTS Complete Response Review Addendum Sponsor Safety Reporting Submissions: NDA 22-433 and IND 65,808 SD 632 Drug: ticagrelor (Brilinta™) Indication: reduce the rate of thrombotic events in patients with acute coronary syndromes (ACS) Sponsor: AstraZeneca Review date: June 8, 2011 Reviewer: Thomas A. Marciniak, M.D (...) . Medical Team Leader On April 20, 2011, we met with AstraZeneca (AZ) staff to discuss progress on the reviews of the complete response for NDA 22-433. Because my review and that of the IND reviewer, Dr. Martin Rose, had suggested significant problems with AZ’s handling of serious adverse events (SAEs), I added to the end of the agenda a discussion of these problems. The minutes for the meeting filed on May 19, 2011, summarize that discussion as follows: “There was some discussion regarding

2011 FDA - Drug Approval Package

171. Chronic obstruction of the antrum of the stomach by a mucosal diaphragm, with malnutrition, impairment of growth and secondary small intestine damage. (PubMed)

Chronic obstruction of the antrum of the stomach by a mucosal diaphragm, with malnutrition, impairment of growth and secondary small intestine damage. 5150064 1972 08 11 2018 11 13 0041-6193 41 1 1971 Winter The Ulster medical journal Ulster Med J Chronic obstruction of the antrum of the stomach by a mucosal diaphragm, with malnutrition, impairment of growth and secondary small intestine damage. 39-44 Irwin J W JW Logan J S JS Porter D C DC eng Journal Article Northern Ireland Ulster Med J (...) 0417367 0041-6193 IM Adolescent Adult Diarrhea etiology Female Growth Disorders etiology Humans Intestinal Diseases etiology Intestine, Small Nutrition Disorders etiology Stomach Diseases complications 1971 1 1 1971 1 1 0 1 1971 1 1 0 0 ppublish 5150064 PMC2385293 Surg Gynecol Obstet. 1968 Nov;127(5):999-1004 5681358 Ulster Med J. 1971;40(2):151-7 5150057 Surgery. 1966 May;59(5):681-4 5931478 Br J Surg. 1949 Oct;37(146):244-6, illust 15395097 Gastroenterology. 1967 Jun;52(6):1003-8 6026482 Br J Surg

Full Text available with Trip Pro

1971 The Ulster medical journal

172. Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit

Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Adjunct Methadone to Decrease the Duration of Mechanical Ventilation in the Medical Intensive Care Unit The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02025855 Recruitment Status : Unknown Verified January 2014 by Thomas Smoot, PharmD, BCPS, Henry

2013 Clinical Trials

173. MEdical Versus SUrgical Treatments of Rectal Endometriosis

MEdical Versus SUrgical Treatments of Rectal Endometriosis MEdical Versus SUrgical Treatments of Rectal Endometriosis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. MEdical Versus SUrgical Treatments (...) of the rectum and not having pregnancy intention. The main outcome concerns the quality of digestive function 24 after the onset of the treatment, assessed using a composite variable: patient considering that digestive function is normal AND the Knowles-Eccersley-Scott-Symptom Questionnaire (KESS score) <7 AND the Gastrointestinal Quality of Life Index (GIQLI) score >100. Secondary outcomes are: presence of severe constipation, increased frequency of daily bowel movements, anal incontinence, postoperative

2013 Clinical Trials

174. Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation

Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study (...) Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov

2013 Clinical Trials

175. A cross-sectional study of the association between overnight call and irritable bowel syndrome in medical students (PubMed)

A cross-sectional study of the association between overnight call and irritable bowel syndrome in medical students Shift work has been associated with irritable bowel syndrome (IBS), which includes gastrointestinal symptoms such as abdominal pain, constipation and diarrhea. Overnight call shifts also lead to a disruption of the endogenous circadian rhythm.Medical students who perform intermittent overnight call shifts will demonstrate a higher prevalence of IBS symptoms when compared (...) measure (IBS-QOL). The prevalence of IBS symptoms and quality of life secondary to those symptoms were determined.Data were available for 247 medical students (110 preclinical students, 118 clerkship students and 19 excluded surveys). There was no significant difference in the presence of IBS between preclinical and clerkship students (21 of 110 [19.1%] versus 26 of 118 [22.0%]; P=0.58). The were no significant differences in mean (± SD) IBS-QOL score of those with IBS between preclinical (43.5±8.3

Full Text available with Trip Pro

2012 Canadian Journal of Gastroenterology

176. A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications

A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. A Clinical Study of a Natural Remedy for Rheumatoid Arthritis vs. Commonly Used Conventional Medications The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01600521 Recruitment Status : Completed First Posted : May 17, 2012 Last Update Posted : April

2012 Clinical Trials

177. A Study in Healthy Volunteers to Evaluate Effects of Pre-Medication or Slow Dose Titration on Flushing and Gastrointestinal Events

, and flatulence) during the 24 hours prior to each AM dose. Participants were to answer the questions at the same time each day, before the morning drug administration. Secondary Outcome Measures : Number of Participants With Treatment-Emergent Adverse Events (AEs) or Serious AEs (SAEs) [ Time Frame: Day 1 up to end of Safety Follow-up (9 weeks) ] AE: any untoward medical occurrence that does not necessarily have a causal relationship with treatment. SAE: any untoward medical occurrence that at any dose (...) A Study in Healthy Volunteers to Evaluate Effects of Pre-Medication or Slow Dose Titration on Flushing and Gastrointestinal Events Effect of Aspirin Pretreatment or Slow Dose Titration on Flushing and Gastrointestinal Events in Healthy Volunteers Receiving Delayed-release Dimethyl Fumarate - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save

2012 Clinical Trials

178. Educational-Medical-Behavioral Treatment of Fecal Incontinence

to be effective in single-site studies will sustain its efficacy when disseminated to a home bound population by home health care nurses. The treatment includes patient education about the physiology of how continence is maintained, pelvic floor exercises, behavioral strategies for preventing FI, and use of fiber or nonprescription medication to treat diarrhea or constipation. To minimize drift when the treatment is disseminated to a large group of providers, patient education and other basic components (...) Educational-Medical-Behavioral Treatment of Fecal Incontinence Educational-Medical-Behavioral Treatment of Fecal Incontinence - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Educational-Medical-Behavioral

2012 Clinical Trials

179. A nonhuman primate model of the hematopoietic acute radiation syndrome plus medical management. (PubMed)

these parameters for a nonhuman primate exposed to total body radiation and administered medical management. A blinded, randomized study (n = 48 rhesus macaques) determined the lethal dose-response relationship using bilateral 6 MV linear accelerator photon radiation to doses in the range of 7.20 to 8.90 Gy at 0.80 Gy min(-1). Following irradiation, animals were monitored for complete bloodcounts, body weight, temperature, diarrhea, and hydration status for 60 d. Animals were administered medical management (...) consisting of intravenous fluids, prophylactic antibiotics, blood transfusions, anti-diarrheals, analgesics, and nutrition. The primary endpoint was survival at 60 d post-irradiation; secondary endpoints included hematopoietic-related parameters, number of transfusions, incidence of documented infection, febrile neutropenia, severity of diarrhea, mean survival time of decedents, and tissue histology. The study defined an LD30/60 of 7.06 Gy, LD50/60 of 7.52 Gy, and an LD70/60 of 7.99 Gy with a relatively

Full Text available with Trip Pro

2012 Health physics

180. Patients Hospitalized with pH1N1 Influenza in an Academic Community Medical Center (PubMed)

consecutive patients that were admitted to our hospital with a primary or secondary diagnosis of influenza from October 1-November 30, 2009. Data were obtained through care of the patients and chart review.Prominent symptoms on admission included fever, hypoxia, cough, myalgias, and diarrhea, with leukocytosis and neutrophilia. Pre-existing medical conditions included asthma, pregnancy, immunosuppressive therapy, and sickle cell disease. All but 5 of the patients were under 60 years of age. Three patients (...) Patients Hospitalized with pH1N1 Influenza in an Academic Community Medical Center The emergence of a novel strain of pandemic influenza (pH1N1) in 2009 presented significant challenges to health care facilities worldwide. In our academic community medical center in suburban Philadelphia, we noted our first pH1N1 diagnosis in September 2009. We sought to assess the impact of pH1N1 disease on our hospitalized patient population.We prospectively collected clinical and epidemiological data on 29

Full Text available with Trip Pro

2011 The open respiratory medicine journal

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>